1. Lepage C, Bouvier AM, Phelip JM, et al (2004) Incidence and management of malignant digestive endocrine tumours in a well-defined French population. Gut 53:549–53
2. Rindi G, Arnold R, Bosman F, et al (2010) Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In: Bosman FT, Carneiro F, Hruban RH, Theise ND (eds) WHO classification of tumours of the digestive system. IARC, Lyon, pp 13–14
3. Plockinger U, Rindi G, Arnold R, et al (2004) Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology 80:394–424
4. Levi F, Te VC, Randimbison L, et al (2000) Epidemiology of carcinoid neoplasms in Vaud, Switzerland, 1974–97. Br J Cancer 83:952–5
5. Niederle MB, Hackl M, Kaserer K, Niederle B (2010) Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters. Endocr Relat Cancer 17:909–18